Filing Details
- Accession Number:
- 0001209191-20-045946
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-10 16:30:51
- Reporting Period:
- 2020-08-06
- Accepted Time:
- 2020-08-10 16:30:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1237831 | Globus Medical Inc | GMED | Surgical & Medical Instruments & Apparatus (3841) | 043744954 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1768417 | Kelly Huller | Valley Forge Business Center 2560 General Armistead Avenue Audubon PA 19403 | Svp, Gc, Corporate Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2020-08-06 | 12,000 | $11.28 | 12,000 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2020-08-06 | 6,000 | $54.78 | 6,000 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2020-08-06 | 3,000 | $55.92 | 3,000 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2020-08-06 | 3,000 | $57.90 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Option (Right to Buy Class A Common Stock) | Disposition | 2020-08-06 | 12,000 | $0.00 | 12,000 | $11.28 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,000 | 2021-02-11 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.90 to $55.98, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- These options were granted on February 11, 2011 and are fully vested.